GetTopicDetailResponse(id=ad51e57330e, topicName=第79屆ADA, introduction=第79屆ADA, content=null, image=null, comments=3, allHits=734, url=https://h5.medsci.cn/topic?id=75733, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=90816, tagList=[TagDto(tagId=90816, tagName=第79屆ADA)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1803701, encodeId=99381803e01d1, content=<a href='/topic/show?id=ad51e57330e' target=_blank style='color:#2F92EE;'>#第79屆ADA#</a>, objectTitle=第79屆ADA：與GLP-1受體激動劑相比，Soliqua/Suliqua顯著降低了2型糖尿病患者的血糖水平, objectType=article, longId=167983, objectId=85e516e98361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85e516e98361, replyNumber=0, likeNumber=102, createdTime=2020-05-02, rootId=0, userName=passed water, userId=a92e2500162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85e516e98361, moduleTitle=第79屆ADA：與GLP-1受體激動劑相比，Soliqua/Suliqua顯著降低了2型糖尿病患者的血糖水平, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=85e516e98361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803700, encodeId=f7ad1803e0032, content=<a href='/topic/show?id=ad51e57330e' target=_blank style='color:#2F92EE;'>#第79屆ADA#</a>, objectTitle=第79屆ADA：Dance 501吸入型胰島素的II期臨床結(jié)果喜人, objectType=article, longId=167971, objectId=033116e97107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=033116e97107, replyNumber=0, likeNumber=88, createdTime=2019-07-03, rootId=0, userName=passed water, userId=a92e2500162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=033116e97107, moduleTitle=第79屆ADA：Dance 501吸入型胰島素的II期臨床結(jié)果喜人, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=033116e97107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1803699, encodeId=fcf5180369981, content=<a href='/topic/show?id=ad51e57330e' target=_blank style='color:#2F92EE;'>#第79屆ADA#</a>, objectTitle=第79屆ADA：雙重GIP和GLP-1受體激動劑tirzepatide治療2型糖尿病的潛力, objectType=article, longId=167970, objectId=f88316e97041, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f88316e97041, replyNumber=0, likeNumber=113, createdTime=2019-06-22, rootId=0, userName=passed water, userId=a92e2500162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f88316e97041, moduleTitle=第79屆ADA：雙重GIP和GLP-1受體激動劑tirzepatide治療2型糖尿病的潛力, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f88316e97041)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
